Fluorodeoxyglucose F18

Displaying 1 - 10 of 10CSV
Chang, Y., Gu, Y., Ruan, S., Xu, S., Sun, J., Jiang, Z., Yao, G., Wang, Z., & Zhao, H. (2024). [18F]FDG PET/CT performs better than CT in determining the bone biopsy site : randomized controlled clinical trial. Cancer Imaging, 24(1). https://doi.org/10.1186/s40644-024-00804-6
Publication Date
Columbia Affiliation
Kang, J. S., Andrews, H. F., Giles, J. T., Liao, K. P., Solomon, D. H., & Bathon, J. M. (2024). Returning Incidental Research Findings From 18F‐Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography to Participants: A Survey of Investigators From a Clinical Trial of Rheumatoid Arthritis. Arthritis Care & Research, 76(12), 1637–1646. Portico. https://doi.org/10.1002/acr.25424
Publication Date
Bartlett, E. A., Lesanpezeshki, M., Anishchenko, S., Shkolnik, I., Ogden, R. T., Mann, J. J., Beylin, D., Miller, J. M., & Zanderigo, F. (2023). Dynamic Human Brain Imaging with a Portable PET Camera: Comparison to a Standard Scanner. Journal of Nuclear Medicine, 65(2), 320–326. https://doi.org/10.2967/jnumed.122.265309
Publication Date
Torka, P., Pederson, L. D., Knopp, M. V., Poon, D., Zhang, J., Kahl, B. S., Higley, H. R., Kelloff, G., Friedberg, J. W., Schwartz, L. H., Wilson, W. H., Leonard, J. P., Bartlett, N. L., Schöder, H., & Ruppert, A. S. (2023). Is local review of positron emission tomography scans sufficient in diffuse large B‐cell lymphoma clinical trials? A CALGB 50303 analysis. Cancer Medicine, 12(7), 8211–8217. Portico. https://doi.org/10.1002/cam4.5628
Publication Date
Nyrén, R., Scherman, H., Axelsson, J., Chang, C. L., Olivecrona, G., & Ericsson, M. (2023). Visualizing increased uptake of [18F]FDG and [18F]FTHA in kidneys from obese high-fat diet fed C57BL/6J mice using PET/CT ex vivo. PLOS ONE, 18(2), e0281705. https://doi.org/10.1371/journal.pone.0281705
Publication Date
Shankar, L. K., Huang, E., Litiere, S., Hoekstra, O. S., Schwartz, L., Collette, S., Boellaard, R., Bogaerts, J., Seymour, L., & deVries, E. G. E. (2022). Meta-Analysis of the Test–Retest Repeatability of [18F]-Fluorodeoxyglucose Standardized Uptake Values: Implications for Assessment of Tumor Response. Clinical Cancer Research, 29(1), 143–153. https://doi.org/10.1158/1078-0432.ccr-21-3143
Publication Date
Ferraz-Amaro, I., Sheikh, A., Polack, B., Giles, J. T., & Bathon, J. M. (2022). Articular18Fluorodeoxyglucose Uptake Is Associated With Clinically Assessed Swollen Joint Count in Patients With Rheumatoid Arthritis. The Journal of Rheumatology, 49(12), 1315–1319. https://doi.org/10.3899/jrheum.220231
Publication Date
Selvaraj, S., Seidelmann, S. B., Soni, M., Bhattaru, A., Margulies, K. B., Shah, S. H., Dugyala, S., Qian, C., Pryma, D. A., Arany, Z., Kelly, D. P., Chirinos, J. A., & Bravo, P. E. (2022). Comprehensive nutrient consumption estimation and metabolic profiling during ketogenic diet and relationship with myocardial glucose uptake on FDG-PET. European Heart Journal - Cardiovascular Imaging, 23(12), 1690–1697. https://doi.org/10.1093/ehjci/jeac031
Publication Date
Manson, G., Lemchukwu, A. C., Mokrane, F.-Z., Lopci, E., Aide, N., Vercellino, L., Houot, R., & Dercle, L. (2022). Interpretation of 2-[18F]FDG PET/CT in Hodgkin lymphoma patients treated with immune checkpoint inhibitors. European Radiology, 32(9), 6536–6544. https://doi.org/10.1007/s00330-022-08669-8
Publication Date
Bartlett, E. A., Ogden, R. T., Mann, J. J., & Zanderigo, F. (2022). Source‐to‐Target Automatic Rotating Estimation (STARE) – A publicly‐available, blood‐free quantification approach for PET tracers with irreversible kinetics: Theoretical framework and validation for [18F]FDG. NeuroImage, 249, 118901. https://doi.org/10.1016/j.neuroimage.2022.118901
Publication Date